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FJHN are caused by lack of normal THP or by the presence of
abnormal THP.
We are one of two groups to generate THP-deficient
(THP/) mice by the technique of homologous recombina-
tion.4 In this study, we investigated if absence of THP in mice
leads to findings similar to those associated with human
mutations of THP. We selected age- and gender-matched
THP/ (n¼ 10) and THPþ /þ (n¼ 10) mice, and allowed
them to receive normal food and drink for 3 years. The mice
were assessed for weight, feeding behavior, and physical
activity. Mice were killed using carbon dioxide narcosis and
dissected. All visceral organs were examined for gross
pathology, and kidneys were processed for histology. The
kidney sections were stained with hematoxylin and eosin,
periodic acid schiff, and Masson’s trichrome stains. A renal
pathologist examined the slides in a blinded manner.
Results showed that there was no difference between the
groups (THP/ and THPþ /þ mice) in their level of
physical activity, weight gain, growth, and general health.
Renal histology was normal in all mice. There were no areas
of fibrosis or cystic change in the cortex or medulla in kidney
sections from either group of mice (Figure 1).
Our results demonstrate that the mere absence of THP is
not sufficient to cause histological changes associated with
MCKD2/FJHN in mice up to 3 years of age.
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To the Editor: In a recent Nephrology Forum, an interesting
survey of endothelial dysfunction mediated by calcineurin
inhibitors and the cellular mechanisms leading to it is given
by Lamas.1 This dysfunction leads to an increased vascular
resistance and hypertension. However, an unmentioned
factor could also contribute to this endothelial dysfunction.
Changes in blood rheology can directly influence the forces
on the vessel wall. Shear stresses can influence endothelial cell
morphology and function. A decreased erythrocyte deform-
ability has been found in patients using cyclosporin, as well as
a higher plasma viscosity, fibrinogen level, and erythrocyte
aggregation.2,3 These rheological disturbances could con-
tribute to endothelial dysfunction: on the other hand, it
could also be suggested that disturbances of the endothelium
could contribute to rheological alterations. The endothelium
and blood could have an interesting interplay in this
respect.
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Steroid resistance in childhood
nephrotic syndrome
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To the Editor: We read with interest the recent article
in Kidney International by Kim et al.1 concerning childhood
nephrotic syndrome. We would like to bring to
their attention our report from nearly 20 years ago
of a cohort of 60 children with initially steroid-responsive
nephritic.2 Forty-nine (82%) had a frequently relapsing or
steroid-dependent course. Twenty of these children were
treated with cyclophosphamide owing to unacceptable
steroid toxicity; all achieved a complete remission that was
sustained in 70% of the children over a mean of 9 years of
additional follow-up, whereas 30% had one or more
subsequent relapse. Of the 29 children not treated with
cyclophosphamide, 52% continued to relapse, whereas 48%
went into a remission that was sustained for between 3 and
16 years, despite the earlier frequently relapsing/steroid-
dependent course. All 20 of the cyclophosphamide-treated
children had kidney biopsies: 10 had minimal change disease;
of these, nine had a permanent remission induced. Six had
focal sclerosis and four had mesangial proliferation; of these,
only five had permanent remission. None of the 60 children
developed renal insufficiency or hypertension. Siegel et al.3
had also earlier reported the frequent occurrence of focal
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